Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ESTC -27.9%, ULTA -8.1%, JKS -3.4%
Other news:
- NCNA -53.4% (announces update for Phase 2 randomized colorectal cancer study)
- ALNY -13.2% (presents detailed results from the positive HELIOS-B phase 3 Study of Vutrisiran in patients with ATTR amyloidosis with cardiomyopathy at the European Society of Cardiology Congress)